查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613191

冠狀動脈疾病市場：按類型、最終用戶分類 - 全球預測 2025-2030

Coronary Artery Disease Market by Type (Diagnostics, Treatment), End-User (Ambulatory Surgery Centers, Diagnostic Centers, Hospitals & Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年冠心病市場價值為118.8億美元，預計到2024年將達到125.3億美元，複合年成長率為5.68%，到2030年將達到174.9億美元。

冠狀動脈疾病 (CAD) 是一種心血管疾病，斑塊堆積會使冠狀動脈變窄並減少流向心臟的血流。這種疾病本質上很嚴重，因為它是全世界死亡的主要原因之一。人口老化的加劇和生活方式的改變增加了風險因素，因此需要對新技術進行深入研究和應用。 CAD 相關的最終用途涵蓋醫院、診斷中心和專科診所，並且越來越關注預防性和微創手術。 CAD 市場的關鍵成長要素包括診斷技術的進步，例如用於預測分析的人工智慧、穿戴式健康監測設備以及遠端醫療的廣泛採用。主要透過基因分析和新型藥物輸送系統對個人化醫療的日益關注，正在為相關人員創造重要的商機。為了利用這些機會，公司應該投資創新治療方法的研發，以解決 CAD 管理中未滿足的需求，例如基因治療、幹細胞治療和生物可吸收支架開發。然而，與先進處理技術相關的高成本和監管挑戰等限制可能會阻礙市場擴張。此外，開發中地區對醫療基礎設施的依賴也是一個突出的挑戰。激烈的市場競爭需要透過技術創新和策略聯盟來實現差異化。創新研究領域包括探索基因靜默中的微型RNA、增強 CAD 中基因組編輯的 CRISPR 以及透過 3D 列印開發心血管生物材料。市場洞察凸顯了新興經濟體作為開拓市場的重要作用，因為醫療保健支出不斷增加。在全面市場分析的支持下，持續創新和策略定位對於希望在動態 CAD 市場中獲得吸引力並擴大影響力的公司至關重要。

主要市場統計
基準年[2023] 118.8億美元
預測年份 [2024] 125.3億美元
預測年份 [2030] 174.9億美元
複合年成長率（%） 5.68%

市場動態：快速發展的冠狀動脈疾病市場的關鍵市場洞察

供應和需求的動態相互作用正在改變冠狀動脈疾病市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 隨著人口老化，冠狀動脈疾病增加
    • 醫療基礎設施投資增加導致醫療基礎建設
  • 市場限制因素
    • 深度處理設備高成本，先進技術商業化有限
  • 市場機會
    • CAD 管理產品的進步與改進
    • 持續擴大微創手術和手術中心
  • 市場挑戰
    • 因安全問題而導致產品召回的問題

波特五力：駕馭冠狀動脈疾病市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解冠狀動脈疾病市場的外部影響

外部宏觀環境因素在塑造冠狀動脈疾病市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解冠狀動脈疾病市場的競爭格局

冠狀動脈疾病市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣冠狀動脈疾病市場供應商的績效評估

FPNV 定位矩陣是評估冠狀動脈疾病市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了冠狀動脈疾病市場的成功之路

冠狀動脈疾病市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化導致冠心病發病率增加
      • 由於醫療基礎設施投資增加而擴大醫療基礎設施
    • 抑制因素
      • 深度處理設備高成本，先進技術商業化受到限制
    • 機會
      • CAD 管理產品的進步與改進
      • 持續擴大微創手術和手術中心
    • 任務
      • 因安全問題而涉及產品召回的問題
  • 市場區隔分析
    • 類型：對手術的需求不斷增加，以有效管理 CAD 並提高生活品質
    • 最終使用者：高度偏好提供全面 CAD 照護的醫院和診所
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 冠狀動脈疾病市場：依類型

  • 診斷
    • 心導管檢查及血管造影術
    • 心臟超音波圖
    • 心電圖
    • 運動壓力測試
    • 心臟電腦斷層掃描
    • 核子壓力測試
  • 治療
    • 藥品
      • 血管張力素轉化酵素抑制劑和血管收縮素II受體阻斷劑硝酸甘油
      • 阿斯匹靈
      • BETA受體阻斷劑
      • 鈣離子通道阻斷劑
      • 膽固醇藥
      • 雷諾嗪
    • 外科手術
      • 冠狀動脈血管成形術和置入術
      • 冠狀動脈繞道手術手術

第7章 冠狀動脈疾病市場：依最終使用者分類

  • 門診手術中心
  • 診斷中心
  • 醫院/診所

第8章美洲冠狀動脈疾病市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區冠心病市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的冠心病市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Abbott 推出改良的 Xience Sierra 支架系統以改善心臟治療
    • 創新Start-Ups利用人工智慧技術徹底改變冠狀動脈疾病檢測
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • B. Braun SE
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Edwards Lifesciences
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Genesee Biomedical Inc.
  • Getinge AB
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Merck KGaA
  • MicroPort Scientific Corporation
  • Siemens Healthineer AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-5D693B46C822

The Coronary Artery Disease Market was valued at USD 11.88 billion in 2023, expected to reach USD 12.53 billion in 2024, and is projected to grow at a CAGR of 5.68%, to USD 17.49 billion by 2030.

Coronary Artery Disease (CAD) falls under cardiovascular diseases involving the narrowing of coronary arteries due to plaque buildup, leading to reduced blood flow to the heart. This condition is inherently critical due to its prevalence as a leading cause of mortality worldwide. The necessity for intensive research and application of new technologies is paramount, driven by the increased aging population and lifestyle changes that heighten risk factors. End-use applications of CAD-related interventions span across hospitals, diagnostic centers, and specialty clinics, with an ever-growing emphasis on preventative and minimally invasive procedures. Key growth factors in the CAD market include advancements in diagnostic technologies such as artificial intelligence for predictive analytics, wearable health-monitoring devices, and the widespread implementation of telemedicine. The burgeoning focus on personalized medicine, mainly through genetic profiling and novel drug delivery systems, presents significant opportunities for stakeholders. To capitalize on these opportunities, companies should invest in R&D for innovative treatment approaches such as gene therapy, stem cell therapies, or the development of bioabsorbable stents, which can address unmet needs in CAD management. However, limitations such as high costs associated with advanced therapeutic technologies and regulatory challenges can impede market expansion. Additionally, the dependency on healthcare infrastructure in developing regions is a notable challenge. The highly competitive market nature necessitates differentiation through technological ingenuity and strategic alliances. Innovative research areas include the exploration of microRNA in gene silencing, enhancement of CRISPR for genome editing in CAD, and development in 3D-printed cardiovascular biomaterials. An insight into the market highlights the crucial role of emerging economies as untapped markets due to their increasing healthcare spending. Overall, continued innovation and strategic positioning, supported by comprehensive market analysis, will be key for businesses aiming to gain traction and expand their footprint in the dynamic CAD market.

KEY MARKET STATISTICS
Base Year [2023] USD 11.88 billion
Estimated Year [2024] USD 12.53 billion
Forecast Year [2030] USD 17.49 billion
CAGR (%) 5.68%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coronary Artery Disease Market

The Coronary Artery Disease Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of coronary artery disease due to aging populations
    • Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
  • Market Restraints
    • High cost of advanced therapeutic devices and limited commercialization of advanced technologies
  • Market Opportunities
    • Advancements and improvements in CAD management products
    • Continuous expansion of minimally invasive procedures and surgery centers
  • Market Challenges
    • Problems associated with product recalls due to safety concerns

Porter's Five Forces: A Strategic Tool for Navigating the Coronary Artery Disease Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coronary Artery Disease Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coronary Artery Disease Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coronary Artery Disease Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coronary Artery Disease Market

A detailed market share analysis in the Coronary Artery Disease Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coronary Artery Disease Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coronary Artery Disease Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coronary Artery Disease Market

A strategic analysis of the Coronary Artery Disease Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronary Artery Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences, FUJIFILM Holdings Corporation, GE HealthCare Technologies, Inc., Genesee Biomedical Inc., Getinge AB, Hitachi, Ltd., Koninklijke Philips N.V., Medtronic PLC, Merck KGaA, MicroPort Scientific Corporation, Siemens Healthineer AG, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Diagnostics and Treatment. The Diagnostics is further studied across Cardiac Catheterization & Angiogram, Echocardiogram, Electrocardiogram, Exercise Stress Test, Heart CT Scan, and Nuclear Stress Test. The Treatment is further studied across Medications and Surgeries. The Medications is further studied across Angiotensin-converting Enzyme Inhibitors & Angiotensin II Receptor Blockers Nitroglycerin, Aspirin, Beta-blockers, Calcium Channel Blockers, Cholesterol Drugs, and Ranolazine. The Surgeries is further studied across Coronary Angioplasty & Stent Placement and Coronary Artery Bypass Graft Surgery.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Diagnostic Centers, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of coronary artery disease due to aging populations
      • 5.1.1.2. Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced therapeutic devices and limited commercialization of advanced technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CAD management products
      • 5.1.3.2. Continuous expansion of minimally invasive procedures and surgery centers
    • 5.1.4. Challenges
      • 5.1.4.1. Problems associated with product recalls due to safety concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing need for surgeries to manage CAD effectively and improve the quality of life
    • 5.2.2. End-User: Higher preferences for hospitals and clinics that offer integrated CAD care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Coronary Artery Disease Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostics
    • 6.2.1. Cardiac Catheterization & Angiogram
    • 6.2.2. Echocardiogram
    • 6.2.3. Electrocardiogram
    • 6.2.4. Exercise Stress Test
    • 6.2.5. Heart CT Scan
    • 6.2.6. Nuclear Stress Test
  • 6.3. Treatment
    • 6.3.1. Medications
      • 6.3.1.1. Angiotensin-converting Enzyme Inhibitors & Angiotensin II Receptor Blockers Nitroglycerin
      • 6.3.1.2. Aspirin
      • 6.3.1.3. Beta-blockers
      • 6.3.1.4. Calcium Channel Blockers
      • 6.3.1.5. Cholesterol Drugs
      • 6.3.1.6. Ranolazine
    • 6.3.2. Surgeries
      • 6.3.2.1. Coronary Angioplasty & Stent Placement
      • 6.3.2.2. Coronary Artery Bypass Graft Surgery

7. Coronary Artery Disease Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Diagnostic Centers
  • 7.4. Hospitals & Clinics

8. Americas Coronary Artery Disease Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Coronary Artery Disease Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Coronary Artery Disease Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Abbott Introduces Enhanced Xience Sierra Stent System for Improved Cardiac Care
    • 11.3.2. Innovative Startup Revolutionizes Coronary Artery Disease Detection with AI Technology
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun SE
  • 3. Becton, Dickinson and Company
  • 4. Biotronik SE & Co. KG
  • 5. Boston Scientific Corporation
  • 6. Canon Medical Systems Corporation
  • 7. Edwards Lifesciences
  • 8. FUJIFILM Holdings Corporation
  • 9. GE HealthCare Technologies, Inc.
  • 10. Genesee Biomedical Inc.
  • 11. Getinge AB
  • 12. Hitachi, Ltd.
  • 13. Koninklijke Philips N.V.
  • 14. Medtronic PLC
  • 15. Merck KGaA
  • 16. MicroPort Scientific Corporation
  • 17. Siemens Healthineer AG
  • 18. Stryker Corporation
  • 19. Teleflex Incorporated
  • 20. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. CORONARY ARTERY DISEASE MARKET RESEARCH PROCESS
  • FIGURE 2. CORONARY ARTERY DISEASE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CORONARY ARTERY DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CORONARY ARTERY DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CORONARY ARTERY DISEASE MARKET DYNAMICS
  • TABLE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIAC CATHETERIZATION & ANGIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EXERCISE STRESS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HEART CT SCAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY NUCLEAR STRESS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS & ANGIOTENSIN II RECEPTOR BLOCKERS NITROGLYCERIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CHOLESTEROL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY RANOLAZINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ANGIOPLASTY & STENT PLACEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. CORONARY ARTERY DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. CORONARY ARTERY DISEASE MARKET, FPNV POSITIONING MATRIX, 2023